Valeant Pharmaceuticals International Inc. announced a series of leadership and organizational changes.
Florida Republican Governor Rick Scott accused the federal government of lagging in providing assistance to combat the spread of the Zika virus in a Miami-area neighborhood, the site of the first U.S. transmission of the virus.
The first new asthma pill in decades has produced promising results in a small study, potentially paving the way for another treatment option by the end of the decade.
Bristol-Myers Squibb’s blockbuster Opdivo failed to slow progression of symptoms in previously untreated patients with advanced lung cancer in a late-stage study.
There is continued fallout among scientists and members of the American Association for Clinical Chemistry (AACC) following the presentation of embattled Theranos head Elizabeth Holmes during the annual meeting in Philadelphia.
The U.S. Food and Drug Administration has a warning for Chinese company Xiamen Origin Biotech – don’t lie. A January inspection of that company’s facilities in China revealed a number of violations by the company, including a false claim that no drugs were kept on site. However, an FDA inspector saw a room that was used to warehouse relabeled medications, StatNews reported. Inspectors also noted that despite being told that Xiamen Origin Biotech has ceased relabeling drugs in January 2015, one year prior to the FDA inspection, investigators “reviewed a list of exported drugs that showed Xiamen had distributed them until January 2016,” StatNews said.
Novo Nordisk cut its forecast for full-year 2016 profit growth and said it expected tough competition in the United States to pressure prices in 2017.
Almost every reported concomitant medication has a reason – and many, if not all of these reasons should be reported as adverse events.
A U.S. advisory panel recommended approval of Egalet Corp.’s long-acting opioid painkiller, Arymo ER, saying it dulls pain and could deter abuse by addicts seeking a quick high.
A portable system that produces tiny batches of biotech drugs might one day help get crucial medicines and vaccines to remote villages and war-torn regions where they are desperately needed, scientists hope.